0000899243-21-005686.txt : 20210210
0000899243-21-005686.hdr.sgml : 20210210
20210210164651
ACCESSION NUMBER: 0000899243-21-005686
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freedman Edward D.
CENTRAL INDEX KEY: 0001817434
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39381
FILM NUMBER: 21614651
MAIL ADDRESS:
STREET 1: C/O PANDION THERAPEUTICS, INC.
STREET 2: 134 COOLIDGE AVE., 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pandion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 833015614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 134 COOLIDGE AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-393-5925
MAIL ADDRESS:
STREET 1: 134 COOLIDGE AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Pandion Therapeutics Holdco LLC
DATE OF NAME CHANGE: 20200327
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-08
0
0001807901
Pandion Therapeutics, Inc.
PAND
0001817434
Freedman Edward D.
C/O PANDION THERAPEUTICS, INC.,
134 COOLIDGE AVENUE
WATERTOWN
MA
02472
0
1
0
0
Chief Operating Officer
Stock Option (right to buy)
17.75
2021-02-08
4
A
0
36895
0.00
A
2031-02-07
Common Stock
36895
36895
D
This option award was granted on February 8, 2021. 1/4 of the shares underlying the award shall vest on February 8, 2022, with the remainder of the shares vesting in equal monthly installments following February 8, 2022 through February 8, 2025, subject to the reporting person's continued service on each applicable vesting date.
/s/ Edward D. Freedman
2021-02-10